fda semaglutide shortage As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A The Wegovy Shortage Continues, Leaving

The Questions You Should Ask Before Starting These medications affect multiple organ systems

In the gym: Your working weights are dropping across multiple sessions You feel weaker during exercises that used to feel manageable Recovery between sessions is slower than it used to be In how you look and feel: You're losing weight but looking and feeling "smaller but softer" rather than leaner Fatigue that goes beyond normal tiredness, especially in the afternoon Hair thinning or increased hair loss - a sign of inadequate protein over time On the scale: Losing weight faster than expected without seeing strength improvements - rapid loss without training and protein often means muscle is going alongside fat If you're noticing two or more of these, increasing protein intake is the first thing to address

Yes, fatigue is listed as a common adverse reaction in the FDA prescribing information for Wegovy (semaglutide 2.4 mg for weight management)

Extreme lipoprotein(a) levels and improved cardiovascular risk prediction

Determining the appropriate amount of vitamin B12 to take depends on several factors, including age, health status, and dietary habits